Cutler Group’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-1,010
| Closed | -$36K | – | 1830 |
|
|
2023
Q3 | $36K | Buy |
+1,010
| New | +$36K | ﹤0.01% | 764 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 2342 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 2350 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 2599 |
|
|
2021
Q1 | – | Sell |
-411
| Closed | -$56K | – | 2540 |
|
|
2020
Q4 | $56K | Buy |
+411
| New | +$56K | ﹤0.01% | 972 |
|
|
2019
Q4 | – | Sell |
-200
| Closed | -$8K | – | 2004 |
|
|
2019
Q3 | $8K | Sell |
200
-300
| -60% | -$12K | ﹤0.01% | 1226 |
|
|
2019
Q2 | $31K | Buy |
+500
| New | +$31K | ﹤0.01% | 1056 |
|
|
2019
Q1 | – | Sell |
-1,821
| Closed | -$79K | – | 2050 |
|
|
2018
Q4 | $79K | Sell |
1,821
-179
| -9% | -$7.77K | 0.01% | 704 |
|
|
2018
Q3 | $152K | Sell |
2,000
-150
| -7% | -$11.4K | 0.01% | 627 |
|
|
2018
Q2 | $165K | Buy |
2,150
+2,000
| +1,333% | +$153K | 0.01% | 557 |
|
|
2018
Q1 | $7K | Sell |
150
-100
| -40% | -$4.67K | ﹤0.01% | 1481 |
|
|
2017
Q4 | $11K | Sell |
250
-2,263
| -90% | -$99.6K | ﹤0.01% | 1583 |
|
|
2017
Q3 | $133K | Buy |
2,513
+785
| +45% | +$41.5K | 0.01% | 885 |
|
|
2017
Q2 | $107K | Buy |
1,728
+1,713
| +11,420% | +$106K | ﹤0.01% | 1159 |
|
|
2017
Q1 | $1K | Sell |
15
-10,695
| -100% | -$713K | ﹤0.01% | 2682 |
|
|
2016
Q4 | $753K | Buy |
10,710
+6,575
| +159% | +$462K | 0.03% | 356 |
|
|
2016
Q3 | $293K | Buy |
+4,135
| New | +$293K | 0.01% | 594 |
|
|
2016
Q2 | – | Sell |
-298
| Closed | -$18K | – | 3261 |
|
|
2016
Q1 | $18K | Buy |
+298
| New | +$18K | ﹤0.01% | 1776 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 3210 |
|